Recent exceptional negative changes in investment behavior have affected United Airlines Holdings Inc (NASDAQ: UAL): the stock’s recent price decline challenged its longer term uptrend, and negative upside/downside volume developed. Recent meaningful negative changes in […]
TrueCar Inc (NASDAQ: TRUE) has reported E.P.S. of $-0.15 for its second fiscal quarter (ending June 30) versus $-0.23 for the same period a year ago. Relative to the consensus estimate of $-0.03, this was […]
QCR Holdings Inc (NASDAQ: QCRH) has benefited from extremely meaningful positive changes in fundamentals: the consensus estimate for December, 2024 increased significantly, the stock’s power rating rose above 70, the consensus estimate for December, 2025 […]
Perma Fix Environmental Services (NASDAQ: PESI) stock suffered a major decline of -10.0% on 8/5/24. The shares closed at $10.70. Moreover, this decline was accompanied by unusually high trading volume at 161% of normal. The […]
Recent significant negative changes in fundamentals have impacted Kaiser Aluminum Corp (NASDAQ: KALU): the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased significantly. […]
Integra LifeSciences Holdings Co (NASDAQ: IART) suffers from meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly. […]
For its second fiscal quarter (ending June 30), Information Services Group Inc (NASDAQ: III) has reported a -20% decline in E.P.S. from $0.05 a year ago to $0.04 in the current quarter. This result fell […]
Golub Capital BDC Inc (NASDAQ: GBDC) has reported earnings for its third fiscal quarter (ending June 30) of $0.05 versus $0.43 for the same period a year ago — a decline of -88%. This result […]
CSX Corp (NASDAQ: CSX) has reported earnings for its second fiscal quarter (ending June 30) of $0.49 versus $0.49 for the same period a year ago — flat performance. This result exceeded the consensus estimate […]
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has reported a loss for its second fiscal quarter (ending June 30) of $-0.06 versus a loss $-0.40 for the same period a year ago. This result exceeded the consensus […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research